EMCDDA Home
  • EN
Search

Table GPS-18. Last year prevalence of drug use among the 15–24 age group in nationwide surveys among the general population. Last survey available for each Member State (from 2000 onwards)

CountryGeographical AreaYearReferenceAge range Sample size (15–24)Cannabis (%)Cocaine (%) (1)Amphetamines (%) (2)Ecstasy (%) (3)LSD (%)
BelgiumNational2004(6)15–24:11.8::::
BulgariaNational2007(2)15–2412537.41.01.62.70.3
Czech RepublicNational2004(2)18–2458628.20.42.212.01.3
DenmarkNational2008(5)16–2487921.35.65.42.30.2
GermanyNational2006(7)18–24186816.81.82.31.80.4
EstoniaNational2003(2)15–2432918.21.85.56.11.5
IrelandNational2006–07(5)15–24:13.13.80.82.80.2
GreeceNational (except Aegean and Ionian Islands)2004(3)15–241 7853.60.20.10.30.2
SpainNational2007-08(7)15–24394324.15.42.02.6:
FranceNational2005(6)15–24466221.71.10.21.10.3
ItalyNational2007(4)15–24232322.63.00.61.1:
CyprusNational2006(1)15–249693.61.00.51.30.7
LatviaNational2007(2)15–24185512.91.32.43.60.6
LithuaniaNational2004(1)15–249237.00.71.21.20.2
Luxembourg::::::::::
HungaryNational2007(3)18–2443310.11.12.72.20.5
MaltaNational2001(1)18–24287:::::
NetherlandsNational2005(3)15–24:11.4::::
AustriaNational2004(1)15–2495915.01.71.92.00.4
PolandNational2006(2)15–2411357.50.31.90.90.5
PortugalNational2007(2)15–2422116.60.70.41.00.4
RomaniaNational2007(2)15–2410601.50.10.10.30.0
Slovenia::::::::::
SlovakiaNational2006(6)15–2428720.41.81.15.3:
FinlandNational2006(7)15–246549.10.91.82.00.5
SwedenNational2007(8)16–246276.0::::
United KingdomEngland and Wales2007-08(11)16–24581917.95.02.43.90.7
United KingdomNorthern Ireland2006-07(15)16–2434217.62.01.43.00.2
United KingdomScotland2006(18)16–2442627.111.05.69.22.0
United KingdomUnited Kingdom2006(20)16–24:21.26.43.65.10.9
Croatia::::::::::
Turkey::::::::::
NorwayNational2004(2)15–2464513.11.42.51.30.3

Notes:

 : indicates data not available 

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions

 For methods of each survey presented in this table, see Table GPS-1 part (ii).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page

                        

Sources:

 See Table GPS-0

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Tuesday, 30 June 2009